NCT01846559View on ClinicalTrials.gov

The Antiplatelet and Immune Response Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
BIOLOGICAL

Endotoxin

E.coli Endotoxin Day 7 - 2 ng/kg

DRUG

Clopidogrel

Clopidogrel (tablet) over 8 days Day 1: 300 mg loading dose Day 2-7: 75 mg orally once daily

DRUG

Ticagrelor

Ticagrelor over 8 days (tablet) Day 1: 180 mg loading dose Day 2-7: 90 mg orally twice daily

Trial Locations (1)

S5 7AU

Sheffield Clinical Research Facility, Sheffield

All Listed Sponsors
collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT01846559 - The Antiplatelet and Immune Response Trial | Biotech Hunter | Biotech Hunter